Torrent’s manufacturing facilities at Indrad meet cGMP guidelines and comply with WHO, cGMP, MHRA and TGA norms.

Regulatory Approvals :

The Finished Dose Formulation facility at Indrad, Gujarat (India) caters to the growing demand for exports of branded generic products. The facility has been approved by following regulatory authorities:

• cGMP (EU)
• BFDA (Taiwan)
• MHRA (UK)
• BfArM (Germany)
  
• TGA (Australia)
  
• Anvisa (Brazil)
  
• MCC (South Africa)
  
• Ministry of Health (Latvia)
  
• MCAZ (Zimbabwe)
  
• NDA (Uganda)
  
• Anvima (Columbia)
  
• National Institute of Pharmacy (Hungary)

Quality Certifications :

• ISO 9001-2000: Quality Management System
• ISO 14001: Environment Management System
• OHSAS 18001: Occupational Health & Safety Management System
• ISO/IEC- 17025 by NABL
  
• Quality Excellence Gold Award, IDMA (Indian Drug Manufacturer’s Association)